Additional file 1 of Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

Leach, Amanda Jane; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Chatfield, Mark D.; Oguoma, Victor M.; Morris, Peter Stanley

doi:10.6084/m9.figshare.14183793.v1

12887_2021_2552_MOESM1_ESM.docx (31.16 kB)

Additional file 1 of Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

journal contribution

posted on 09.03.2021, 04:41 authored by Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Peter Stanley Morris

Additional file 1 Supplementary Table 1: Comparisons of proportion of infants with a worst ear diagnosis* of any otitis media or bilateral OM, by vaccine group and age (months).